The official letter No. 22098/QLD-ĐK: Unifying indications of drugs containing Alpha chymotrypsin following by oral route, sublingual route

1043
The official letter No. 22098/QLD-ĐK
The official letter No. 22098/QLD-ĐK
5/5 - (5 bình chọn)
    MINISTRY OF HEALTH

DRUG ADMINISTRATION OF VIET NAM

SOCIALIST REPUBLIC OF VIETNAM

Independence – Freedom – Happiness

——o0o—–

 

No. 22098/QLD-ĐK: Unifying indications of drugs containing Alpha chymotrypsin following by oral route, sublingual route Hanoi, December 26, 2017

To:

– Provincial/Municipal Health Services

– Hospitals, institutes with beds directly under Ministry of Health

– Drug registration applicants

Aims to ensure the safe and effective use of drugs and unify the indications of drugs containing Alpha chymotrypsin following by oral route or sublingual route, Drug Administration of Vietnam requests as follow:

I. For drug registration applicants in Viet Nam:

1. For drugs containing Alpha chymotrypsin following by oral route or sublingual route granted registration numbers:

1.1. Within 03 months from signing date of this official letter, drug registration applicants are requested to conduct the change of writing therapeutic indications of this medicine on the label and instruction for use ……………………

Dowload file for full version…

1.2. Form of update: drug registration applicants conduct the update pursuant to the regulation under Clause 4 Article 9 Circular 44/2014/TT-BYT dated November 25, 2014 of the Ministry of Health on drug registration.

2. For registration dossiers of drugs containing Alpha chymotrypsin following by oral route or sublingual route in process of approving at Drug Administration of Vietnam:

Drug Administration of Vietnam only considers to submit to Drug Registration Advisory Committee after Drug registration applicant submit supporting document of indications in related part of registration dossier as per above instruction in Section 1.1 and be validated that meeting requirement.

II. Provincial/Municipal Health Services and Hospitals, institutes with beds directly under Ministry of Health

Report to medical facilities, drug business facilities in respective localities about the change of label and instruction for use of drugs containing Alpha chymotrypsin following by oral route or sublingual route in above section 1.1.
Drug administration of Vietnam notifies the facilities to know and comply.

For General Director

Vice General Director

(signed and sealed)

Do Van Dong

Copy please to refer vnras.com

The official letter No. 22098/QLD-ĐK Vietnamese version and original letter here

DOWNLOAD FULL ENGLISH VERSION HERE: 22098_QLD_ĐK_2017_ENGLISH

Translated by Minh Van

Ngày viết:
Vietnam Regulatory Affairs Society. Join us, VNRAS, feel free to contact. We'll provide you all information and regulatory affairs update related to products covered by the Ministry of Health of Vietnam (drug, vaccine, biological, pharmaceutical raw material, excipient, capsule, traditional medicine, herbal medicine, medical equipment, invitro diagnostic medical devices, cosmetic, food supplements, chemical and preparation for medical and household use).
LEAVE A REPLY
Please enter your comment!